carbamates has been researched along with Dyskinesia, Drug-Induced in 6 studies
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although levodopa improves PD symptoms in the initial stages of the disease, its long-term use is limited by the development of side effects, including abnormal involuntary movements (dyskinesias) and psychiatric complications." | 1.34 | Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. ( Cassano, T; Cuomo, V; Giuffrida, A; Morgese, MG, 2007) |
| "= 2." | 1.29 | D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. ( Bartsch, R; Engel, J; Hönack, D; Kutscher, B; Löscher, W; Polymeropoulos, EE; Rostock, A; Rundfeldt, C; Tober, C; White, HS; Wolf, HH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, TH | 1 |
| Huot, P | 1 |
| Fox, SH | 1 |
| Wakefield, JD | 1 |
| Sykes, KA | 1 |
| Bartolini, WP | 1 |
| Milne, GT | 1 |
| Pearson, JP | 1 |
| Brotchie, JM | 1 |
| Sander, SE | 1 |
| Lemm, C | 1 |
| Lange, N | 1 |
| Hamann, M | 1 |
| Richter, A | 1 |
| Morgese, MG | 1 |
| Cassano, T | 1 |
| Cuomo, V | 1 |
| Giuffrida, A | 1 |
| Rostock, A | 1 |
| Tober, C | 1 |
| Rundfeldt, C | 1 |
| Bartsch, R | 1 |
| Engel, J | 1 |
| Polymeropoulos, EE | 1 |
| Kutscher, B | 1 |
| Löscher, W | 1 |
| Hönack, D | 1 |
| White, HS | 1 |
| Wolf, HH | 1 |
| Heinze, M | 1 |
| Andreae, D | 1 |
| Grohmann, R | 1 |
| Leinot, M | 1 |
| Benoit, J | 1 |
| Basiez, M | 1 |
| Meunier, A | 1 |
| Labrid, C | 1 |
6 other studies available for carbamates and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease.
Topics: Amides; Amidohydrolases; Animals; Benzamides; Callithrix; Carbamates; Disease Models, Animal; Dyskin | 2011 |
Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.
Topics: Amantadine; Aminopyridines; Animals; Anticonvulsants; Antiparkinson Agents; Behavior, Animal; Carbam | 2012 |
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.
Topics: Amidohydrolases; Animals; Antiparkinson Agents; Arachidonic Acids; Basal Ganglia; Benzamides; Benzox | 2007 |
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.
Topics: Administration, Oral; Animals; Anticonvulsants; Behavior, Animal; Bicuculline; Carbamates; Dyskinesi | 1996 |
Rivastigmin and impaired motor function.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Catatonia; Dyskinesia, Drug-Induced; Female; | 2002 |
[Comparaison, in the mouse, of two treatments for alcohol withdrawal syndrome. Inhibition of oxo tremorine-induced tremor, sedative and motor effects (author's transl)].
Topics: Alcoholism; Animals; Antipsychotic Agents; Barbiturates; Benzamides; Carbamates; Dyskinesia, Drug-In | 1979 |